In conclusion, TLR4-HMGB1 signaling axis is a relevant pathway for survival of HPV-positive tumor cells, which warrants further studies to evaluate its potential as a therapeutic target or tumor biomarker. This evidence concerns the gene HMGB1 and neoplasm.